DekaBank Deutsche Girozentrale Decreases Holdings in Henry Schein, Inc. $HSIC

Key Points

• DekaBank Deutsche Girozentrale reduced its stake in Henry Schein, Inc. by 0.8% during the second quarter, holding approximately 953,792 shares valued at $69.9 million after the sale.
• Henry Schein reported earnings of $1.10 per share for the last quarter, missing analysts' estimates of $1.19, but revenue rose 3.3% year-over-year to $3.24 billion.
• Analysts have mixed opinions on Henry Schein, with a consensus price target of $76.67 and several ratings ranging from "Buy" to "Hold."

DekaBank Deutsche Girozentrale lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 0.8% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 953,792 shares of the company's stock after selling 7,369 shares during the period. DekaBank Deutsche Girozentrale owned approximately 0.78% of Henry Schein worth $69,912,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. GAMMA Investing LLC raised its stake in shares of Henry Schein by 37.8% during the 1st quarter. GAMMA Investing LLC now owns 3,939 shares of the company's stock valued at $270,000 after buying an additional 1,081 shares during the last quarter. Wealth Enhancement Advisory Services LLC increased its position in shares of Henry Schein by 0.5% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 53,134 shares of the company's stock worth $3,639,000 after purchasing an additional 243 shares in the last quarter. State of Alaska Department of Revenue boosted its position in Henry Schein by 2.8% during the first quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company's stock worth $1,000,000 after acquiring an additional 395 shares during the last quarter. Oppenheimer Asset Management Inc. increased its holdings in shares of Henry Schein by 5.2% in the first quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company's stock valued at $941,000 after purchasing an additional 678 shares during the last quarter. Finally, Moran Wealth Management LLC purchased a new position in shares of Henry Schein during the 1st quarter worth $3,977,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Henry Schein Trading Up 0.5%

NASDAQ:HSIC opened at $64.23 on Wednesday. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The stock has a market cap of $7.79 billion, a P/E ratio of 20.72, a P/E/G ratio of 2.11 and a beta of 0.81. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The stock has a 50-day simple moving average of $67.01 and a 200-day simple moving average of $68.56.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). The business had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.Henry Schein's revenue was up 3.3% on a year-over-year basis. During the same period last year, the business posted $1.23 EPS. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on HSIC shares. Robert W. Baird reissued a "neutral" rating and set a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research report on Monday, July 14th. Baird R W lowered shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Evercore ISI raised shares of Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 target price on the stock in a research note on Tuesday, August 26th. Leerink Partners set a $75.00 price target on shares of Henry Schein in a research report on Monday, July 14th. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Henry Schein in a research note on Wednesday, October 8th. Five analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.